Primary site stereotactic ablative body radiotherapy in localized, recurrent, and metastatic renal cell carcinoma

Authors: Huang, Daniel, Lynch, Connor, Serra, Lucas M., Sweis, Randy F., Chang, Paul J., Stadler, Walter M., Szmulewitz, Russell Z., O’Donnell, Peter H., Sidana, Abhinav, Eggener, Scott E., Shalhav, Arieh L., Liauw, Stanley L., Pitroda, Sean P.

Source: In Clinical and Translational Radiation Oncology November 2024 49

Clinical Outcomes of Enzalutamide in Metastatic Hormone-sensitive Prostate Cancer in Patients Aged

Authors: Gomez-Veiga, Francisco, Szmulewitz, Russell Z., Holzbeierlein, Jeffrey, Azad, Arun A., Iguchi, Taro, Villers, Arnauld, Alcaraz, Antonio, Alekseev, Boris, Shore, Neal D., Rosbrook, Brad, Zohren, Fabian, Ma, Jie, Haas, Gabriel P., Stenzl, Arnulf, Armstrong, Andrew J.

Source: In European Urology Oncology August 2024 7(4):860-869

Hormonal Therapy and Radiation Therapy in Prostate Cancer: 5-Year Outcomes From a Trial Evaluating Combined Androgen Blockade With 5-Alpha Reductase Inhibitors as an Alternative to Gonadotropin Releasing Hormone Agonists

Authors: Rajeev-Kumar, Greeshma, Pitroda, Sean P., Szmulewitz, Russell Z., Skolarus, Ted, Eggener, Scott E., Liauw, Stanley L.

Source: In Clinical Genitourinary Cancer August 2024 22(4)

Bladder-Preserving Trimodality Therapy With Capecitabine

Authors: Lynch, Connor, Sweis, Randy F., Modi, Parth, Agarwal, Piyush K., Szmulewitz, Russell Z., Stadler, Walter M., O'Donnell, Peter H., Liauw, Stanley L., Pitroda, Sean P.

Source: In Clinical Genitourinary Cancer April 2024 22(2):476-482

The Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Oligometastatic Hormone-sensitive Prostate Cancer: A Post Hoc Analysis of ARCHES

Authors: Armstrong, Andrew J., Iguchi, Taro, Azad, Arun A., Villers, Arnauld, Alekseev, Boris, Petrylak, Daniel P., Szmulewitz, Russell Z., Alcaraz, Antonio, Shore, Neal D., Holzbeierlein, Jeffrey, Gomez-Veiga, Francisco, Rosbrook, Brad, Zohren, Fabian, Haas, Gabriel P., Gourgiotti, Georgia, El-Chaar, Nader, Stenzl, Arnulf

Source: European urology. 84(2):229-241

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100194154906.0x000001&indx=1&recIds=ETOCvdc_100194154906.0x000001

SOX2 expression in prostate cancer drives resistance to nuclear hormone receptor signaling inhibition through the WEE1/CDK1 signaling axis

Authors: Williams, Anthony, Gutgesell, Lisa, de Wet, Larischa, Selman, Phillip, Dey, Arunangsu, Avineni, Mahati, Kapoor, Isha, Mendez, Megan, Brown, Ryan, Lamperis, Sophia, Blajszczak, Chuck, Bueter, Eric, Kregel, Steven, Vander Griend, Donald J., Szmulewitz, Russell Z.

Source: In Cancer Letters 1 July 2023 565

Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer

Authors: Armstrong, Andrew J., Azad, Arun A., Iguchi, Taro, Szmulewitz, Russell Z., Petrylak, Daniel P., Holzbeierlein, Jeffrey, Villers, Arnauld, Alcaraz, Antonio, Alekseev, Boris, Shore, Neal D., Gomez-Veiga, Francisco, Rosbrook, Brad, Zohren, Fabian, Yamada, Shunsuke, Haas, Gabriel P., Stenzl, Arnulf

Source: Journal of clinical oncology. 40(15):1616-1622

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100152855159.0x000001&indx=1&recIds=ETOCvdc_100152855159.0x000001

The impact of enzalutamide on quality of life in men with metastatic hormone‐sensitive prostate cancer based on prior therapy, risk, and symptom subgroups

Authors: Stenzl, Arnulf, Szmulewitz, Russell Z., Petrylak, Daniel, Holzbeierlein, Jeffrey, Villers, Arnauld, Azad, Arun, Alcaraz, Antonio, Alekseev, Boris, Iguchi, Taro, Shore, Neal D., Gomez‐Veiga, Francisco, Ivanescu, Cristina, Rosbrook, Brad, Ramaswamy, Krishnan, Ganguli, Arijit, Haas, Gabriel P., Armstrong, Andrew J.

Source: Prostate. 82(13):1237-1247

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100158355418.0x000001&indx=1&recIds=ETOCvdc_100158355418.0x000001

Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer by Pattern of Metastatic Spread: ARCHES Post Hoc Analyses

Authors: Armstrong, Andrew J., Shore, Neal D., Szmulewitz, Russell Z., Petrylak, Daniel P., Holzbeierlein, Jeffrey, Villers, Arnauld, Azad, Arun, Alcaraz, Antonio, Alekseev, Boris, Iguchi, Taro, Gomez-Veiga, Francisco, Rosbrook, Brad, Lee, Ho-Jin, Haas, Gabriel P., Stenzl, Arnulf

Source: Journal of urology. 205(5):1361-1371

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100184810370.0x000001&indx=1&recIds=ETOCvdc_100184810370.0x000001

Catalyzing Pharmacogenomic Analysis for Informing Pain Treatment (C-PAIN): A Randomized Trial of Preemptive CYP2D6 Genotyping in Cancer Palliative Care.

Authors: Cho, Youngwoo, Karrison, Theodore, Jack, Matthew M, Choksi, Anish R, Knoebel, Randall W, Yeo, Kiang-Teck J, Volchenboum, Samuel L, Szmulewitz, Russell Z, Vokes, Everett E, Ratain, Mark J, O'Donnell, Peter H

Source: Journal of Pain Research; Dec2024, Vol. 17, p4187-4196, 10p

Subject Terms: CLINICAL decision support systems, EMERGENCY room visits, CANCER pain, CYTOCHROME P-450 CYP2D6, GENETIC variation

Effect of Enzalutamide plus Androgen Deprivation Therapy on Health-related Quality of Life in Patients with Metastatic Hormone-sensitive Prostate Cancer: An Analysis of the ARCHES Randomised, Placebo-controlled, Phase 3 Study

Authors: Stenzl, Arnulf, Dunshee, Curtis, De Giorgi, Ugo, Alekseev, Boris, Iguchi, Taro, Szmulewitz, Russell Z., Flaig, Thomas W., Tombal, Bertrand, Morlock, Robert, Ivanescu, Cristina, Ramaswamy, Krishnan, Saad, Fred, Armstrong, Andrew J.

Source: In European Urology October 2020 78(4):603-614

Slow-, Tight-Binding Inhibition of CYP17A1 by Abiraterone Redefines Its Kinetic Selectivity and Dosing Regimen

Authors: Cheong, Eleanor Jing Yi, Nair, Pramod C., Neo, Rebecca Wan Yi, Tu, Ho Thanh, Lin, Fu, Chiong, Edmund, Esuvaranathan, Kesavan, Fan, Hao, Szmulewitz, Russell Z., Peer, Cody J., Figg, William D., Chai, Christina Li Lin, Miners, John O., Chan, Eric Chun Yong ^*

Source: In The Journal of Pharmacology and Experimental Therapeutics September 2020 374(3):438-451

Safety and Efficacy of Hypofractionated Radiotherapy With Capecitabine in Elderly Patients With Urothelial Carcinoma

Authors: Leng, Jim, Akthar, Adil S., Szmulewitz, Russell Z., O’Donnell, Peter H., Sweis, Randy F., Pitroda, Sean P., Smith, Norm, Steinberg, Gary D., Liauw, Stanley L.

Source: In Clinical Genitourinary Cancer February 2019 17(1):e12-e18

Phase I Study of DSTP3086S, an Antibody-Drug Conjugate Targeting Six-Transmembrane Epithelial Antigen of Prostate 1, in Metastatic Castration-Resistant Prostate Cancer

Authors: Danila, Daniel C., Szmulewitz, Russell Z., Vaishampayan, Ulka

Source: Journal of clinical oncology. 37(36):3518-3527

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN622461077&indx=1&recIds=ETOCRN622461077

ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer

Authors: Armstrong, Andrew J., Szmulewitz, Russell Z., Petrylak, Daniel P.

Source: Journal of clinical oncology. 37(32):2974-2986

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN622069361&indx=1&recIds=ETOCRN622069361

Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal Carcinoma

Authors: Sweis, Randy F., Medved, Milica, Towey, Shannon, Karczmar, Gregory S., Oto, Aytekin, Szmulewitz, Russell Z., O'Donnell, Peter H., Fishkin, Paul, Karrison, Theodore, Stadler, Walter M.

Source: In Clinical Genitourinary Cancer April 2017 15(2):207-212

Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer

Authors: Szmulewitz, Russell Z., Peer, Cody J., Ibraheem, Abiola

Source: Journal of clinical oncology. 36(14):1389-1395

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN615823889&indx=1&recIds=ETOCRN615823889

Editorial Comment

Authors: Skolarus, Ted A., Szmulewitz, Russell Z.

Source: Journal of urology. 208(5):996-996

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100183181273.0x000001&indx=1&recIds=ETOCvdc_100183181273.0x000001

MP27-14 OVERALL SURVIVAL IN PATIENTS WITH METASTATIC HORMONE-SENSITIVE PROSTATE CANCER TREATED WITH ENZALUTAMIDE OR PLACEBO PLUS ANDROGEN DEPRIVATION THERAPY WHO HAD PRIOR LOCAL THERAPY: POST HOC ANALYSIS OF THE PHASE 3 ARCHES TRIAL

Authors: Iguchi, Taro, Villers, Arnauld, Shore, Neal D., Azad, Arun A., Szmulewitz, Russell Z., Holzbeierlein, Jeffrey, Alcaraz, Antonio, Alekseev, Boris, Gomez-Veiga, Francisco, Rosbrook, Brad, Lee, Ho-Jin, Haas, Gabriel P., Armstrong, Andrew J., Stenzl, Arnulf

Source: Journal of urology. 207(5):e455-e455

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100165586065.0x000001&indx=1&recIds=ETOCvdc_100165586065.0x000001

New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells

Authors: Taylor, Jennifer L., Szmulewitz, Russell Z., Lotan, Tamara, Hickson, Jonathan, Griend, Donald Vander, Yamada, Seiko Diane, Macleod, Kay, Rinker-Schaeffer, Carrie W.

Source: In Cancer Letters 8 December 2008 272(1):12-22